Rockwell Medical, Inc NT 10-K, filed Mar 17, 2020
Rockwell Medical, Inc. (RMTI)
NT 10-K
2020-03-17
For: 2020-03-16
View Original
Added on
October 18, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC File Number: 000-23661
CUSIP Number: 774374102
(Check one): | x Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR | |
For Period Ended: December 31, 2019 | ||
☐ Transition Report on Form 10-K | ||
☐ Transition Report on Form 10-Q | ||
For the Transition Period Ended: | ||
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. |
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART I — REGISTRANT INFORMATION
Rockwell Medical Inc.
Full Name of Registrant
Former Name if Applicable
411 Hackensack Avenue, Suite 501
Address of Principal Executive Office (Street and Number)
Hackensack, NJ 07601
City, State and Zip Code
PART II — RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
x | (a) | The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense; | ||
(b) | The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and | |||
(c) | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. | |||
PART III — NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, or N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.
The Registrant’s Annual Report on Form 10-K for the period ended December 31, 2019 cannot be filed within the prescribed time period without unreasonable effort or expense because of a delay in the completion of the Registrant’s financial statements resulting from its entry into a Loan and Security Agreement on the date hereof, which needed to be reflected in the financial statements.
PART IV — OTHER INFORMATION
(1 | ) | Name and telephone number of person to contact in regard to this notification | |||||
Angus Smith | (248) | 432-1997 | |||||
(Name) | (Area Code) | (Telephone Number) | |||||
(2 | ) | Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s). x Yes ☐ No | |||||
(3 | ) | Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ☒ Yes x No | |||||
Rockwell Medical Inc.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
Date | March 16, 2020 | By | /s/ Angus Smith | |||||||
Angus Smith | ||||||||||
Chief Financial Officer (Principal Financial Officer) | ||||||||||